Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Positive Patients in Sub-Saharan Africa

Alcoholism: Clinical and Experimental Research

Volumn 36, Issue 5, 2012, Pages 854-862

  Hahn, Judith A ^a   Dobkin, Loren M ^b   Mayanja, Bernard ^c   Emenyonu, Nneka I ^a,b   Kigozi, Isaac M ^c   Shiboski, Stephen ^a   Bangsberg, David R ^c,d,e   Gnann, Heike ^f   Weinmann, Wolfgang ^f,g   Wurst, Friedrich M ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY OF BERN   (Switzerland)

^h PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Africa; Alcohol; Biomarker; HIV; Phosphatidylethanol

Indexed keywords

BIOLOGICAL MARKER; PHOSPHATIDYLETHANOL; UNCLASSIFIED DRUG;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BREATH TESTS; FEMALE; GLYCEROPHOSPHOLIPIDS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; ROC CURVE; UGANDA; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84860435281     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01669.x     Document Type: Article

References (60)

1. Aalto M, Alho H, Halme JT, Seppa K (2009) AUDIT and its abbreviated versions in detecting heavy and binge drinking in a general population survey. Drug Alcohol Depend 103:25-29.
2. Acuda SW, Sebit MB (1997) Prevalence of psychoactive substance use among psychiatric in-patients in Harare, Zimbabwe. Cent Afr J Med 43:226-229.
3. Adomakoh CC (1976) Alcoholism: the African scene. Ann NY Acad Sci 273:39-46.
4. Alt A, Janda I, Seidl S, Wurst FM (2000) Determination of ethyl glucuronide in hair samples. Alcohol Alcohol 35:313-314.
5. Anton RF (2010) Editorial commentary: alcohol biomarker papers. Alcohol Clin Exp Res 34:939-940.
6. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, Locastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003-2017.
7. Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C (2006) Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 41:431-437.
8. Aradottir S, Moller K, Alling C (2004a) Phosphatidylethanol formation and degradation in human and rat blood. Alcohol Alcohol 39:8-13.
9. Aradottir S, Seidl S, Wurst FM, Jonsson BA, Alling C (2004b) Phosphatidylethanol in human organs and blood: a study on autopsy material and influences by storage conditions. Alcohol Clin Exp Res 28:1718-1723.
10. Babor T, Higgins-Biddle J, Saunders J, Monteiro MG (2001) The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. World Health Organization, Department of Mental Health and Substance Dependence, Geneva, Switzerland.
11. Bearer CF, Bailey SM, Hoek JB, Freeman WM, Vrana KE (2010) Advancing alcohol biomarkers research. Alcohol Clin Exp Res 34:941-945.
12. Bergstrom JP, Helander A (2008) Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta 388:59-67.
13. Dahl H, Stephanson N, Beck O, Helander A (2002) Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide. J Anal Toxicol 26:201-204.
14. Del Boca FK, Darkes J (2003) The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 98(Suppl 2):1-12.
15. Del Boca FK, Noll JA (2000) Truth or consequences: the validity of self-report data in health services research on addictions. Addiction 95(Suppl 3):S347-S360.
16. Delong ER, Delong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845.
17. Fisher JC, Bang H, Kapiga SH (2007) The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis 34:856-863.
18. Freeman WM, Vrana KE (2010) Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders. Alcohol Clin Exp Res 34:946-954.
19. Gillis LS, Stone GL (1977) The fate of drinkers: a six-year follow-up study of a community survey. S Afr Med J 51:789-791.
20. Gnann H, Engelmann C, Skopp G, Winkler M, Auwarter V, Dresen S, Ferreiros N, Wurst FM, Weinmann W (2010) Identification of 48 homologues of phosphatidylethanol in blood by LC-ESI-MS/MS. Anal Bioanal Chem 396:2415-2423.
21. Gnann H, Weinmann W, Engelmann C, Wurst FM, Skopp G, Winkler M, Thierauf A, Auwarter V, Dresen S, Bouzas NF (2009) Selective detection of phosphatidylethanol homologues in blood as biomarkers for alcohol consumption by LC-ESI-MS/MS. J Mass Spectrom 44:1293-1299.
22. Gunnarsson T, Karlsson A, Hansson P, Johnson G, Alling C, Odham G (1998) Determination of phosphatidylethanol in blood from alcoholic males using high-performance liquid chromatography and evaporative light scattering or electrospray mass spectrometric detection. J Chromatogr B Biomed Sci Appl 705:243-249.
23. Hahn JA, Maier M, Byakika-Tusiime J, Oyugi JH, Bangsberg DR (2007) Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda. J Int Assoc Physicians AIDS Care 6:83-86.
24. Hahn JA, Samet JH (2010) Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep 7:226-233.
25. Hahn JA, Woolf-King SE, Muyindike W (2011) Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa. Curr HIV/AIDS Rep 8:172-180.
26. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ (2007) Biochemical markers of alcoholism. Clin Chem Lab Med 45:953-961.
27. Hansson P, Caron M, Johnson G, Gustavsson L, Alling C (1997) Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 21:108-110.
28. Harrison L, Hughes A (1997) Introduction-the validity of self-reported drug use: improving the accuracy of survey estimates. NIDA Res Monogr 167:1-16.
29. Hartmann S, Aradottir S, Graf M, Wiesbeck G, Lesch O, Ramskogler K, Wolfersdorf M, Alling C, Wurst FM (2007) Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict Biol 12:81-84.
30. Helander A, Beck O (2005) Ethyl sulfate: a metabolite of ethanol in humans and a potential biomarker of acute alcohol intake. J Anal Toxicol 29:270-274.
31. Helander A, Wielders JP, Jeppsson JO, Weykamp C, Siebelder C, Anton RF, Schellenberg F, Whitfield JB (2010) Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material. Clin Chem Lab Med 48:1585-1592.
32. Helander A, Zheng Y (2009) Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 55:1395-1405.
33. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM (2009) Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 52:180-202.
34. Hietala J, Koivisto H, Anttila P, Niemela O (2006) Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 41:528-533.
35. Isaksson A, Walther L, Hansson T, Andersson A, Alling C (2011) Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Test Anal 3:195-200.
36. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, Bangsberg DR, Hahn JA (2009) Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr 52:280-289.
37. Litten RZ, Bradley AM, Moss HB (2010) Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res 34:955-967.
38. Marques P, Hansson T, Isaksson A, Walther L, Jones J, Lewis D, Jones M (2011) Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Inj Prev 12:136-141.
39. Miller WR, Heather N, Hall W (1991) Calculating standard drink units: international comparisons. Addiction 86:43-47.
40. Morini L, Politi L, Polettini A (2009) Ethyl glucuronide in hair. A sensitive and specific marker of chronic heavy drinking. Addiction 104:915-920.
41. Mwesigye PK, Okurut TO (1995) A survey of the production and consumption of traditional alcoholic beverages in Uganda. Process Biochem 30:497-501.
42. Neumann T, Neuner B, Gentilello LM, Weiss-Gerlach E, Mentz H, Rettig JS, Schroder T, Wauer H, Muller C, Schutz M, Mann K, Siebert G, Dettling M, Muller JM, Kox WJ, Spies CD (2004) Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department. Alcohol Clin Exp Res 28:1693-1701.
43. NIAAA (2004) NIAAA Council Approves Definition of Binge Drinking. NIAAA Newsletter, Bethesda, MD.
44. Niemela O (2007) Biomarkers in alcoholism. Clin Chim Acta 377:39-49.
45. Nissinen AE, Laitinen LM, Kakko S, Helander A, Savolainen MJ, Horkko S (in press) Low plasma antibodies specific for phosphatidylethanol in alcohol abusers and patients with alcoholic pancreatitis. Addict Biol [Epub ahead of print].
46. Obot IS (1990) Substance abuse, health and social welfare in Africa: an analysis of the Nigerian experience. Soc Sci Med 31:699-704.
47. Omoluabi PF (1995) A review of the incidence of nonprescription psychoactive substance use/misuse in Nigeria. Int J Addict 30:445-458.
48. Papas RK, Sidle JE, Wamalwa ES, Okumu TO, Bryant KL, Goulet JL, Maisto SA, Braithwaite RS, Justice AC (2010) Estimating alcohol content of traditional brew in Western Kenya using culturally relevant methods: the case for cost over volume. AIDS Behav 14:836-844.
49. Parry CD (2005) South Africa: alcohol today. Addiction 100:426-429.
50. Parry CD, Bhana A, Myers B, Pluddemann A, Flisher AJ, Peden MM, Morojele NK (2002) Alcohol use in South Africa: findings from the South African Community Epidemiology Network on Drug Use (SACENDU) project. J Stud Alcohol 63:430-435.
51. Rehm J, Rehn N, Room R, Monteiro M, Gmel G, Jernigan D, Frick U (2003) The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res 9:147-156.
52. Stewart SH, Law TL, Randall PK, Newman R (2010) Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res 34:488-492.
53. Stewart SH, Reuben A, Brzezinski WA, Koch DG, Basile J, Randall PK, Miller PM (2009) Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol 44:464-467.
54. Varga A, Hansson P, Johnson G, Alling C (2000) Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 299:141-150.
55. Varga A, Hansson P, Lundqvist C, Alling C (1998) Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers. Alcohol Clin Exp Res 22:1832-1837.
56. WHO (2011) Global Status Report on Alcohol and Health. World Health Organization, Geneva.
57. Wurst FM, Dresen S, Allen JP, Wiesbeck G, Graf M, Weinmann W (2006) Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 101:204-211.
58. Wurst FM, Metzger J (2002) The ethanol conjugate ethyl glucuronide is a useful marker of recent alcohol consumption. Alcohol Clin Exp Res 26:1114-1119.
59. Wurst FM, Seidl S, Ladewig D, Muller-Spahn F, Alt A (2002) Ethyl glucuronide: on the time course of excretion in urine during detoxification. Addict Biol 7:427-434.
60. Wurst FM, Thon N, Aradottir S, Hartmann S, Wiesbeck GA, Lesch O, Skala K, Wolfersdorf M, Weinmann W, Alling C (2010) Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol 15:88-95.